Oncology/Hematology
Other Cancers
More in Other Cancers
Only 16% of discharge doses were within 5 MME of inpatient daily consumption, study showed
Jul 02, 2023
In phase III study, recombinant VWF not superior to cheaper alternative for type 1 and 2 cases
Jun 29, 2023
Increased risk described as "modest," and no association seen with aggressiveness of cancer
Jun 27, 2023
Factors associated with greater likelihood of withdrawal included Hispanic ethnicity, older age
Jun 22, 2023
Continuing Medical Education
1.00 CME Credits